The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy
The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy is a paper indexed in PICO Portal from OpenAlex.
How many citations does The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy have?
The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy has 309 citations in the OpenAlex counts PICO Portal stores.
When was The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy published?
The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy has 2010 year in the PICO Portal index.
What is the open-access status of The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy?
The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy has bronze oa status in the PICO Portal index.
What is the DOI of The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy?
The DOI for The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy is on the source record.
What is the PMID of The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy?
The PMID for The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy is on the source record.
What is the OpenAlex record for The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy?
The OpenAlex for The Role of <sup>68</sup>Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on <sup>111</sup>In-DTPA-Octreotide Scintigraphy is on the source record.